Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

AMLXAMLX
18 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in AMYLYX PHARMACEUTICALS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 725,030 shares of AMLX (AMYLYX PHARMACEUTICALS INC), worth $13M as of 2026-Q2. The position was increased (+1.2% shares). AMLX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$13M

Current Shares

725,030

Total Value Change

+$12.1M

Total Shares Change

+652,003

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
725,030
+1.2%
$13M0.0%$17.96
28
2026-Q1
Increased
716,225
+0.5%
$10M0.0%$14.11
28
2025-Q4
Increased
712,990
+10.5%
$8.6M0.0%$12.00
30
2025-Q3
Increased
645,185
+9.7%
$8.8M0.0%$14.90
30
2025-Q2
Increased
588,411
+57.8%
$3.8M0.0%$6.33
38
2025-Q1
Increased
372,853
+24.7%
$1.3M0.0%$3.66
31
2024-Q4
Decreased
298,949
-1.1%
$1.1M0.0%$3.84
0
2024-Q3
Decreased
302,270
-42.0%
$979,3550.0%$3.08
0
2024-Q2
Increased
521,619
+19.7%
$991,0760.0%$1.90
30
2024-Q1
Increased
435,903
+12.5%
$1.2M0.0%$2.84
28
2023-Q4
Increased
387,620
+6.0%
$5.7M0.0%$14.72
29
2023-Q3
Increased
365,862
+12.4%
$6.7M0.0%$18.31
31
2023-Q2
Increased
325,482
+1.7%
$7M0.0%$20.98
28
2023-Q1
Increased
320,086
+0.7%
$9.4M0.0%$27.71
28
2022-Q4
Increased
317,719
+32.0%
$11.7M0.0%$36.95
36
2022-Q3
Increased
240,739
+241.9%
$6.8M0.0%$30.19
44
2022-Q2
Decreased
70,409
-3.6%
$1.4M0.0%$18.18
0
2022-Q1
New
73,027
-
$939,0000.0%$14.93
35

Other major holders of AMLX: FMR LLC, VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used